Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...

Diversity and inclusion are critical to business success, particularly when fostering innovation and creativity. At Mednet, ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

As part of PCOS Awareness Month, Dr Tayyibah Ali takes a look at the ways employers can help support colleagues with chronic conditions like PCOS ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pharming Group’s Joenja (leniolisib) to treat patients with the rare immune disease activated phosphoinositide 3-kinase ...

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

During a recent media audit on sickle cell disease, an intriguing pattern emerged that the name ‘Christopher’ was the third most mentioned term. This unexpected finding resonated with me, as I share ...